Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder

Mise à jour : Il y a 4 ans
Référence : NCT00143091

Femme et Homme

Extrait

A six week, fixed dose, double-blind, double-dummy, placebo, and active controlled, multicentre trial to evaluate the safety and efficacy of CP-316,311 in outpatients with major depressive disorder.


Critère d'inclusion

  • Depressive Disorder, Major

Liens